Showing results (41-50 of 604) with videos related to
Sort By:
Pageof 61
Pharmacoeconomics - Open|July 13, 2021
Cost-Effectiveness of Peer-Educator-Delivered Lifestyle Modification for Type 2 Diabetes Prevention in a Young Healthy Population in Sri Lanka: A Trial-Based Economic Evaluation and Economic ModelJames Shearer, Miral Kalyani, Anastasios Mangelis, et al.Pharmacoeconomics - Open|April 11, 2019
Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)Osvaldo Ulises Garay, Marie Libérée Nishimwe, Marwân-Al-Qays Bousmah, et al.Pharmacoeconomics - Open|April 11, 2019
Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic ReviewPablo E Pergola, Roberto Pecoits-Filho, Wolfgang C Winkelmayer, et al.Pharmacoeconomics - Open|May 1, 2019
The Costs of Industry-Sponsored Medical Device Clinical Trials in AlbertaIlke Akpinar, Arto Ohinmaa, Lars Thording, et al.Pharmacoeconomics - Open|June 28, 2021
Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UKT Alexander Russell-Smith, James Brockbank, Carla Mamolo, et al.Pharmacoeconomics - Open|June 6, 2022
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare Sector SettingSabine Michelsen Raunbak, Anne Sig Sørensen, Louise Hansen, et al.Pharmacoeconomics - Open|June 19, 2022
Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM TrialMatthew Reaney, Prithvi Addepalli, Veleka Allen, et al.Pharmacoeconomics - Open|July 7, 2022
Costs and Effects of Implementing Digital Tomosynthesis in a Population-Based Breast Cancer Screening Program: Predictions Using Results from the To-Be Trial in NorwayTron Anders Moger, Åsne Holen, Berit Hanestad, et al.Pharmacoeconomics - Open|January 11, 2021
Disparities in the Wage-and-Salary Earnings, Determinants, and Distribution of Health Economics, Outcomes Research, and Market Access Professionals: An Exploratory StudyIoana Popovici, Manuel J Carvajal, Patti Peeples, et al.Pharmacoeconomics - Open|November 20, 2020
Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in FranceBruno Detournay, Zahra Boultif, Amar Bahloul, et al.Pageof 61